Skip to main navigation Skip to search Skip to main content

4-Methyl-5-phenyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type I

  • Yuping Zhu
  • , Steven H. Olson
  • , Anne Hermanowski-Vosatka
  • , Steven Mundt
  • , Kashmira Shah
  • , Marty Springer
  • , Rolf Thieringer
  • , Samuel Wright
  • , Jianying Xiao
  • , Hratch Zokian
  • , James M. Balkovec
  • Merck

Research output: Contribution to journal › Article › peer-review

34 Scopus citations

Abstract

4-Methyl-5-phenyl-(1,2,4)-triazoles were identified as selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1). They were active in vitro and in an in vivo mouse pharmacodynamic (PD) model. The synthesis and structure activity relationships are presented.

Original languageEnglish
Pages (from-to)3405-3411
Number of pages7
JournalBioorganic and Medicinal Chemistry Letters
Volume18
Issue number11
DOIs
StatePublished - 1 Jun 2008

Keywords

  • 11β-HSD1
  • 4-Methyl-5-phenyl triazole
  • Metabolic syndrome

Fingerprint

Dive into the research topics of '4-Methyl-5-phenyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type I'. Together they form a unique fingerprint.

Cite this